Tag: British American Tobacco

  • Daily Beast: BAT Backing Vape Group

    Daily Beast: BAT Backing Vape Group

    Photo: freshidea

    British American Tobacco is the driving force behind the World Vapers Alliance (WVA), a pro-vaping group presenting itself as a grassroots initiative of anti-smoking initiatives, according to the Daily Beast.

    According to the investigation, BAT sought to use the WVA to organize individuals to pressure government officials, including members of the European parliament, to roll back regulations on tobacco products such as bans on flavored products, health warnings and increased taxes. 

    BAT went to great lengths to conceal its involvement with the World Vapers’ Alliance, according to the investigation. Yet, sources and internal documents reviewed as part of the investigation revealed that BAT “has played a central and hands-on role in orchestrating, directing and funding the World Vapers’ Alliance.”

    Anti-smoking groups were aghast. “Tobacco companies like British American Tobacco claim that they are changed, responsible companies working to reduce the enormous harm caused by their products. But their actions tell a different story and show that they continue to use the same deceptive tactics they have always used, including front groups, to fight public health policies and protect their sales and profits,” said Matthew L. Myers, president of the Campaign for Tobacco-Free Kids, in a statement.

    Writing for Vaping360, Jim McDonald said BAT’s involvement with WVA was no secret among vaping advocates, “which is probably a major reason why the organization only has 20,000 individual members, despite extensive social media efforts,” he wrote.

    According to McDonald, many vapers tend to mistrust and resent involvement in vaping issues by the tobacco industry, partly because companies like BAT subsidiary Reynolds American Inc. have gone out of their way to eliminate the competition posed by independent vaping businesses.

    McDonald cites a 2014 RAI comment to the FDA, “essentially offering the agency a blue-print for destroying the open-system vaping industry.”

  • BAT Creates Plant-Based Technology Firm

    BAT Creates Plant-Based Technology Firm

    Photo: BAT

    BAT today announced the launch of KBio Holdings to accelerate the research, development and production of novel treatments. KBio will leverage the plant-based technology capabilities of BAT and Kentucky BioProcessing, BAT’s U.S. plant biologics organization.

    KBio will explore new opportunities to develop its plant-based production system, which has the potential to offer greater speed, scale-up opportunity and thermostability. The new company will focus on delivering treatments for rare and infectious diseases by realizing and expanding the potential of both the plant-based technology platform as well as its existing clinical and preclinical vaccines and antibody pipeline.

    KBio will look to form innovative R&D collaborations and financing aimed at expanding its pipeline and future portfolio, with an ambition of financial self-sufficiency.

    Supporting the company’s future plans, a standalone operational structure for KBio is being established. This includes building a new executive leadership team led by Patrick Doyle as the CEO of KBio. Doyle brings more than 20 years of experience leading innovative biotech companies.

    “I am excited by the opportunity to build on the significant accomplishments made by BAT and KBP,” said Doyle in a statement. “I am confident in the potential of KBio’s powerful plant-based platform, capabilities and emerging early-stage pipeline. To date, the technology has demonstrated its ability to produce novel antibody and vaccine candidates with high purity at a fraction of the time and cost of current technologies. The speed and efficiency demonstrated by the KBio platform has significant potential. This could enable us to progress to clinical studies faster than industry norms in the hope of delivering treatment solutions more quickly.”

    “Science and innovation are fundamental to BAT and delivering on our purpose of building ‘A Better Tomorrow,’” said David O’Reilly, BAT’s director of scientific research. “We recognize the potential of our innovative plant-based technology and have established KBio to maximize that potential. We are excited to see what the future holds.”